Acclinate

Acclinate is a leading brand in the field of clinical trial software companies, dedicated to achieving better results by promoting diversity in clinical trials. Their innovative software is designed to support clinical trial diversity, ensuring that the benefits of these trials are accessible to all. Acclinate understands the importance of inclusivity and aims to integrate culture and technology to achieve better outcomes for minority communities.

They provide access to health-related content that specifically caters to the needs and concerns of minority populations, allowing individuals to connect with others in their community and share valuable perspectives and insights. Acclinate also offers relevant and reputable resources to assist individuals on their health journey. Furthermore, Acclinate's e-DICT platform offers valuable insights gathered from engagement with minority communities.

Researchers can query this platform to view aggregated, de-identified data on potential participants who match their trial's inclusion/exclusion criteria. This enables researchers to present their trials to eligible participants who are most likely to participate. Acclinate is committed to driving health equity through diversity and inclusion in genomic research and clinical trials.

They value relationships and strive to include minorities in conversations as human beings, fostering trust in the process. Trusted by renowned organizations like Rett Syndrome, Acclinate is dedicated to helping healthcare organizations reach and engage diverse individuals, families, and communities through their NOWINCLUDED platform. To improve the diversity of your clinical trials and boost patient outcomes, get started with Acclinate today.

Contact them to learn more about their comprehensive solutions